VirusBank Platform publications

Nirmatrelvir-resistant SARS-CoV-2 is efficiently transmitted in female Syrian hamsters and retains partial susceptibility to treatment

Johan Neyts
Nat Commun. 2023

Combination of the parent analogue of remdesivir (GS-441524) and molnupiravir results in a markedly potent antiviral effect in SARS-CoV-2 infected Syrian hamsters

Johan Neyts
Front Pharmacol. 2022

A SCID Mouse Model To Evaluate the Efficacy of Antivirals against SARS-CoV-2 Infection

Rana Abdelnabi & Johan Neyts
Journal of Virology 2022
More innovative science from the VirusBank team will be coming soon.